Skip Navigation
ChemIDplus Lite•Browse•Advanced

Substance Name: Phenylbutazone [USP:INN:BAN:JAN]
RN: 50-33-9
UNII: GN5P7K3T8S
InChIKey: VYMDGNCVAMGZFE-UHFFFAOYSA-N

Note

  • A butyl-diphenyl-pyrazolidinedione that has anti-inflammatory, antipyretic, and analgesic activities. It has been used in ANKYLOSING SPONDYLITIS; RHEUMATOID ARTHRITIS; and REACTIVE ARTHRITIS.

Molecular Formula

  • C19-H20-N2-O2

Molecular Weight

  • 308.379
 

Classification Codes

Classification Codes

  • Analgesics
  • Analgesics, Non-Narcotic
  • Anti-Inflammatory Agents
  • Anti-Inflammatory Agents, Non-Steroidal
  • Antirheumatic
  • Antirheumatic Agents
  • Drug / Therapeutic Agent
  • Human Data
  • Mutation Data
  • Peripheral Nervous System Agents
  • Reproductive Effect
  • Sensory System Agents
  • Skin / Eye Irritant
  • Tumor Data

Superlist Classification Code

  • Overall Carcinogenic Evaluation: Group 3
* denotes mobile formatted website

Links to Resources

NLM Resources (File Locators)

Regulatory Agencies (Superlist Locators)

Other Resources (Internet Locators)


Search for this InChIKey on the Web

Names and Synonyms

Name of Substance

  • Phenylbutazone
  • Phenylbutazone [USP:INN:BAN:JAN]

MeSH Heading

  • Phenylbutazone

Synonyms

  • 1,2-Diphenyl-3,5-dioxo-4-butylpyrazolidine
  • 1,2-Diphenyl-4-butyl-3,5-dioxopyrazolidine
  • 1,2-Diphenyl-4-butyl-3,5-pyrazolidinedione
  • 3,5-Dioxe-4 buty-1, diphenyl-pyrazolidine
  • 3,5-Dioxo-1,2-diphenyl-4-n-butyl-pyrazolidin
  • 3,5-Dioxo-1,2-diphenyl-4-n-butylpyrazolidine
  • 3,5-Pyrazolidinedione, 4-butyl-1,2-diphenyl-
  • 4-Butyl-1,2-diphenyl-3,5-dioxopyrazolidine
  • 4-Butyl-1,2-diphenyl-3,5-pyrazolidinedione
  • 4-n-Butyl-1,2-diphenyl-3,5-pyrazolidinedione
  • 5-24-05-00400 (Beilstein Handbook Reference)
  • A 7514
  • Alindor
  • Alkabutazona
  • Alqoverin
  • Anerval
  • Anpuzone
  • Antadol
  • Anuspiramin
  • Arthrizon
  • Artrizin
  • Artrizone
  • Artropan
  • Azobutyl
  • Azolid
  • B.t.z.
  • Benzone
  • Betazed
  • Bizolin
  • Bizolin 200
  • BRN 0290080
  • Bunetzone
  • Busone
  • Buta phen
  • Butacompren
  • Butacote
  • Butadion
  • Butadiona
  • Butadione
  • Butadionum
  • Butagesic
  • Butalgina
  • Butalidon
  • Butaluy
  • Butaphen
  • Butapirazol
  • Butapirazole
  • Butapyrazole
  • Butarecbon
  • Butartril
  • Butartrina
  • Butazina
  • Butazolidin
  • Butazolidine
  • Butazona
  • Bute
  • Butidiona
  • Butiwas-simple
  • Butone
  • Butoz
  • Butylpyrin
  • Buvetzone
  • Buzon
  • CCRIS 2374
  • Chembutazone
  • DA-192
  • Digibutina
  • Diossidone
  • Diozol
  • Diphebuzol
  • Diphenylbutazone
  • Ecobutazone
  • EINECS 200-029-0
  • Elmedal
  • Equi bute
  • Equipalazone
  • Eributazone
  • Exrheudon N
  • Febuzina
  • Fenartil
  • Fenibutal
  • Fenibutasan
  • Fenibutazona
  • Fenibutol
  • Fenilbutazon
  • Fenilbutazona
  • Fenilbutazona [INN-Spanish]
  • Fenilbutazone
  • Fenilbutazone [DCIT]
  • Fenilbutina
  • Fenilbutine
  • Fenilidina
  • Fenotone
  • Fenylbutazon
  • Flexazone
  • G 13,871
  • G 13871
  • HSDB 3159
  • Ia-BuT
  • Intalbut
  • Intrabutazone
  • Intrazone
  • Ipsoflame
  • Kadol
  • Lingel
  • Malgesic
  • Mephabutazon
  • Mephabutazone
  • Merizone
  • Nadazone
  • Nadozone
  • NCI-C56531
  • Neo-zoline
  • Novophenyl
  • NSC 25134
  • PBZ
  • Phebuzin
  • Phebuzine
  • Phen-Buta-Vet
  • Phenbutazol
  • Phenopyrine
  • Phenyl-mobuzon
  • Phenylbutaz
  • Phenylbutazon
  • Phenylbutazon [German]
  • Phenylbutazone
  • Phenylbutazonum
  • Phenylbutazonum [INN-Latin]
  • Phenyzone
  • Pirarreumol B
  • Praecirheumin
  • Pyrabutol
  • Pyrazolidin
  • Rectofasa
  • Reudo
  • Reudox
  • Reumasyl
  • Reumazin
  • Reumazol
  • Reumune
  • Reumuzol
  • Reupolar
  • Robizon-V
  • Robizone
  • Robizone-V
  • Rubatone
  • Scanbutazone
  • Schemergen
  • UNII-GN5P7K3T8S

Systematic Names

  • 3,5-Pyrazolidinedione, 4-butyl-1,2-diphenyl-
  • Phenylbutazone

Superlist Name

  • Phenylbutazone

Registry Numbers

CAS Registry Number

  • 50-33-9

FDA UNII

  • GN5P7K3T8S

Other Registry Number

  • 4297-92-1

System Generated Number

  • 0000050339

Structure Descriptors

InChI

InChI=1S/C19H20N2O2/c1-2-3-14-17-18(22)20(15-10-6-4-7-11-15)21(19(17)23)16-12-8-5-9-13-16/h4-13,17H,2-3,14H2,1H3

InChIKey

VYMDGNCVAMGZFE-UHFFFAOYSA-N

Smiles

CCCCC1C(=O)N(N(C1=O)c2ccccc2)c3ccccc3

Toxicity

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
cat LD50 intravenous 100mg/kg (100mg/kg)   Arzneimittel-Forschung. Drug Research. Vol. 19, Pg. 36, 1969.
dog LD50 intravenous 121mg/kg (121mg/kg) BEHAVIORAL: ANALGESIA Archives Internationales de Pharmacodynamie et de Therapie. Vol. 149, Pg. 571, 1964.
dog LD50 oral 332mg/kg (332mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY)

LUNGS, THORAX, OR RESPIRATION: DYSPNEA		 Oyo Yakuri. Pharmacometrics. Vol. 20, Pg. 265, 1980.
guinea pig LD50 oral 250mg/kg (250mg/kg)   Arzneimittel-Forschung. Drug Research. Vol. 19, Pg. 1207, 1969.
hamster LD50 oral 1260mg/kg (1260mg/kg)   Archives of Toxicology, Supplement. Vol. 7, Pg. 365, 1984.
mammal (species unspecified) LD50 intraperitoneal 300mg/kg (300mg/kg) BEHAVIORAL: ANALGESIA European Journal of Medicinal Chemistry--Chimie Therapeutique. Vol. 21, Pg. 277, 1986.
mammal (species unspecified) LD50 oral 700mg/kg (700mg/kg) BEHAVIORAL: ANALGESIA European Journal of Medicinal Chemistry--Chimie Therapeutique. Vol. 21, Pg. 277, 1986.
man TDLo oral 17500ug/kg/3W (17.5mg/kg) KIDNEY, URETER, AND BLADDER: "CHANGES IN TUBULES (INCLUDING ACUTE RENAL FAILURE, ACUTE TUBULAR NECROSIS)"

KIDNEY, URETER, AND BLADDER: URINE VOLUME DECREASED		 Annals of Internal Medicine. Vol. 41, Pg. 1075, 1954.
man TDLo oral 2426mg/kg/24H (2426mg/kg)   Annals of Emergency Medicine. Vol. 20, Pg. 204, 1991.
man TDLo oral 2426mg/kg/24H (2426mg/kg) LUNGS, THORAX, OR RESPIRATION: DYSPNEA

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD		 Annals of Emergency Medicine. Vol. 20, Pg. 204, 1991.
man TDLo unreported 200mg/kg/5W-I (200mg/kg) KIDNEY, URETER, AND BLADDER: HEMATURIA

KIDNEY, URETER, AND BLADDER: URINE VOLUME DECREASED

VASCULAR: BP ELEVATION NOT CHARACTERIZED IN AUTONOMIC SECTION		 British Medical Journal. Vol. 282, Pg. 950, 1981.
mouse LD50 intramuscular 430mg/kg (430mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES

BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)		 Oyo Yakuri. Pharmacometrics. Vol. 13, Pg. 97, 1977.
mouse LD50 intraperitoneal 128mg/kg (128mg/kg)   Pharmaceutical Chemistry Journal Vol. 19, Pg. 33, 1985.
mouse LD50 intravenous 90mg/kg (90mg/kg)   Arzneimittel-Forschung. Drug Research. Vol. 19, Pg. 36, 1969.
mouse LD50 oral 238mg/kg (238mg/kg)   Pharmacological Research Communications. Vol. 18, Pg. 241, 1986.
mouse LD50 subcutaneous 230mg/kg (230mg/kg)   Journal of Pharmacy and Pharmacology. Vol. 7, Pg. 1022, 1955.
mouse LD50 unreported 128mg/kg (128mg/kg)   Farmatsevtichnii Zhurnal Vol. (5), Pg. 26, 1983.
rabbit LD50 intravenous 146mg/kg (146mg/kg) BEHAVIORAL: ATAXIA

LUNGS, THORAX, OR RESPIRATION: DYSPNEA

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD		 Arzneimittel-Forschung. Drug Research. Vol. 10, Pg. 129, 1960.
rabbit LD50 oral 781mg/kg (781mg/kg) BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY)

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

LUNGS, THORAX, OR RESPIRATION: DYSPNEA		 Oyo Yakuri. Pharmacometrics. Vol. 20, Pg. 265, 1980.
rat LD50 intramuscular 220mg/kg (220mg/kg)   Arzneimittel-Forschung. Drug Research. Vol. 10, Pg. 665, 1960.
rat LD50 intraperitoneal 142mg/kg (142mg/kg)   Farmaco, Edizione Scientifica. Vol. 14, Pg. 347, 1959.
rat LD50 intravenous 100mg/kg (100mg/kg)   Arzneimittel-Forschung. Drug Research. Vol. 10, Pg. 665, 1960.
rat LD50 oral 245mg/kg (245mg/kg) BEHAVIORAL: ANALGESIA Archives Internationales de Pharmacodynamie et de Therapie. Vol. 123, Pg. 48, 1959.
rat LD50 subcutaneous 230mg/kg (230mg/kg) BEHAVIORAL: TREMOR

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)		 Oyo Yakuri. Pharmacometrics. Vol. 6, Pg. 1285, 1972.
women TDLo oral 168mg/kg/4W-I (168mg/kg) VASCULAR: OTHER CHANGES

KIDNEY, URETER, AND BLADDER: CHANGES PRIMARILY IN GLOMERULI		 Archives of Internal Medicine. Vol. 145, Pg. 685, 1985.
women TDLo unreported 40mg/kg/4D-I (40mg/kg) BLOOD: LEUKOPENIA

BLOOD: AGRANULOCYTOSIS		 Problemy Gematologii i Perelivaniia Krovi. Problems of Hematology and Blood Transfusion. Vol. 4(5), Pg. 48, 1959.

Physical Properties

Physical Property Value Units Temp (deg C) Source
Melting Point 105 deg C   EXP
pKa Dissociation Constant 4.5 (none)   EXP
log P (octanol-water) 3.16 (none)   EXP
Water Solubility 47.5 mg/L 30 EXP
Vapor Pressure 2.97E-10 mm Hg 25 EST
Henry's Law Constant 6.56E-09 atm-m3/mole 25 EST
Atmospheric OH Rate Constant 3.29E-11 cm3/molecule-sec 25 EST

Physical property data is provided to ChemIDplus by SRC, Inc.